DRAVP ID Peptide Name Source Target Organism Patent No
DRAVPa1741 Sequence 9 from Patent US 7476649 B2 Sos scrofus(pig) Infuenza Virus,Vaccinia Virus,HIV US 7476649 B2
DRAVPa1742 Sequence 10 from Patent US 7476649 B2 Sos scrofus(pig) Infuenza Virus,Vaccinia Virus,HIV US 7476649 B2
DRAVPa1743 Sequence 11 from Patent US 7476649 B2 Sos scrofus(pig) Infuenza Virus,Vaccinia Virus,HIV US 7476649 B2
DRAVPa1744 Sequence 12 from Patent US 7476649 B2 Sos scrofus(pig) Infuenza Virus,Vaccinia Virus,HIV US 7476649 B2
DRAVPa1745 P9 Synthetic construct SARS-CoV-2 US20230165936 A1
DRAVPa1746 P9R Synthetic construct SARS-CoV-2 US20230165936 A1
DRAVPa1747 PS19 Synthetic construct ASFV US 8592552 B2
DRAVPa1748 RS27 Synthetic construct ASFV US 8592552 B2
DRAVPa1749 SS20 Synthetic construct ASFV US 8592552 B2
DRAVPa1750 RS28 Synthetic construct ASFV US 8592552 B2
DRAVPa1751 COVA1 Synthetic construct ASFV US 8592552 B2
DRAVPa1752 PEP1 Synthetic construct ASFV US 8592552 B2
DRAVPa1753 Sequence 1 from Patent US20090233868 A1 Human La protein HCV US20090233868 A1
DRAVPa1754 Sequence 2 from Patent US20090233868 A1 Human La protein  HCV US20090233868 A1
DRAVPa1755 Sequence 10 from Patent CN104072579 B Synthetic construct HIV CN104072579 B
DRAVPa1756 Sequence 2 from Patent CN104072579 B Synthetic construct HIV CN104072579 B
DRAVPa1757 Sequence 13 from Patent CN104072579 B Synthetic construct H5N1 CN104072579 B
DRAVPa1758 Sequence 12 from Patent CN104072579 B Synthetic construct H5N1 CN104072579 B
DRAVPa1759 Sequence 1 from Patent US20110135676 B2 Synthetic construct AIV US20110135676 B2
DRAVPa1760 Sequence 2 from Patent US20110135676 B2 Synthetic construct AIV US20110135676 B2
First 85 86 87 88 89 90 91 Last